SPOP and cancer: In an experimental study, Cyclin D-CDK4 kinase destabilizes PD-L1 via culliculin 3-SPOP to control cancer surveillance: treatment of cells with proteasome or ubiquitin E3 ligase inhibitors incremented PD-L1 expression.